Macrolide analogues of the novel immunosuppressant sanglifehrin: New application of the ring-closing metathesis reaction

Angewandte Chemie - International Edition

Volumn 38, Issue 16, 1999, Pages 2443-2446

  Martin Cabrejas, Luisa M ^a   Rohrbach, Stefan ^a   Wagner, Dieter ^a   Kallen, Jörg ^a   Zenke, Gerhard ^a   Wagner, Jürgen ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Immunosuppressants; Metathesis; Natural products

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MACROLIDE; SANGLIFEHRIN; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; DRUG ACTIVITY; DRUG BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROGEN BOND; HYDROLYSIS; ISOMERISM; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

EID: 0033549744     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3773(19990816)38:16<2443::AID-ANIE2443>3.0.CO;2-B     Document Type: Article

References (42)

1. For a recent review on cyclosporin, see J. Kallen, V. Mikol, V. F. J. Quesniaux, M. D. Walkinshaw, E. Schneider-Scherzer, K. Schörgendorfer, G. Weber, H. G. Fliri in Biotechnology, Vol. 7 (Eds.: H. Kleinkauf, H. von Döhren), WILEY-VCH, Weinheim, 1997, chap. 12, pp. 535-591.
2. The result of these efforts was the isolation of two novel immunosuppressants, rapamycin and FK506, which also inhibit intracellular signaling pathways. For a comprehensive overview of their mode of action, see Perspectives in Drug Discovery and Design, Vol. 2 (Eds.: P. S. Anderson, G. L. Kenyon, G. R. Marshall), ESCOM Science, Leiden, 1994, pp. 3-248.
3. a) S. L. Schreiber, M. W. Albers, E. J. Brown, Acc. Chem. Res. 1993, 26, 412-420;
4. b) S. L. Schreiber, G. R. Crabtree, Immunol. Today 1992, 13, 136-142.
5. a) J. Liu, J. D. Farmer, Jr., W. S. Lane, J. Friedman, I. Weissman, S. L. Schreiber, Cell 1991 66, 807-815;
6. b) J. Friedman, I. Weissman, Cell 1991, 66, 799-806.
7. a) J.-J. Sanglier, V. Quesniaux, T. Fehr, H. Hofmann, M. Mahnke, K. Memmert, W. Schuler, G. Zenke, L. Gschwind, C. Maurer, W. Schilling, J. Antibiot. 1999, 52, 466-473;
8. b) T. Fehr, J. Kallen, L. Oberer, J.-J. Sanglier, W. Schilling, J. Antibiot. 1999, 52, 474-479;
9. c) The details of the X-ray crystallographic structure analysis will be published elsewhere.
10. The affinity of the substrates for cyclophilin A was assessed in a competitive binding assay. The procedure was identical to that described in the following reference, except that CsA coupled to bovine serum albumin (BSA) was replaced by SFA coupled to BSA: H. Schneider, N. Charara, R. Schmitz, S. Wehrli, V. Mikol, M. G. M. Zurini, V. F. J. Quesniaux, N. R. Movva, Biochemistry 1994, 33, 8218-8224.
11. T. Fehr, L. Oberer, V. Quesniaux Ryffel, J.-J. Sanglier, W. Schuler, R. Sedrani (Sandoz Ltd), WO-A 9702285 A1, 1997.
12. a) P. Schwab, M. B. France, J. W. Ziller, R. H. Grubbs, Angew. Chem. 1995, 107, 2179-2181; Angew. Chem. Int. Ed. Engl. 1995, 34, 2039-2041;
13. a) P. Schwab, M. B. France, J. W. Ziller, R. H. Grubbs, Angew. Chem. 1995, 107, 2179-2181; Angew. Chem. Int. Ed. Engl. 1995, 34, 2039-2041;
14. b) for a recent review on RCM, see R. H. Grubbs, S. Chang, Tetrahedron 1998, 54, 4413-4450.
15. K. J. Hale, J. Cai, V. Delisser, S. Manaviazar, S. A. Peak, G. S. Bhatia, T. C. Collins, N. Jogiya, Tetrahedron 1996, 52, 1047-1068.
16. U. Schöllkopf, U. Groth, C. Deng, Angew. Chem. 1981, 93, 793-795; Angew. Chem. Int. Ed. Engl. 1981, 20, 798-799.
17. U. Schöllkopf, U. Groth, C. Deng, Angew. Chem. 1981, 93, 793-795; Angew. Chem. Int. Ed. Engl. 1981, 20, 798-799.
18. R. Bänteli, I. Brun, P. Hall, R. Metternich, Tetrahedron Lett. 1999, 40, 2109-2112.
19. T. Shioiri, T. Imaeda, Y. Hamada, Heterocycles 1997, 46, 421-442.
20. a) R. V. Stevens, R. E. Cherpeck, B. L. Harrison, J. Lai, R. Lapalme, J. Am. Chem. Soc. 1976, 98, 6317-6321;
21. b) T. R. Hoye, A. S. Magee, W. S. Trumper, Synth. Commun. 1982, 12, 183-187.
22. H20,H21 = 15.0 and 14.4 Hz for 1 and 2, respectively.
23. a) S. J. Miller, H. E. Blackwell, R. H. Grubbs, J. Am. Chem. Soc. 1996, 118, 9606-9614;
24. b) A. Fürstner, K. Langemann, J. Am. Chem. Soc. 1997, 119, 9130-9136;
25. c) Z. Xu, C. W. Johannes, A. F. Houri, D. S. La, D. A. Cogan, G. E. Hofilena, A. H. Hoveyda, J. Am. Chem. Soc. 1997, 119, 10302-10316;
26. d) A. Fürstner, K. Langemann, Synthesis 1997, 792-803;
27. e) K. C. Nicolaou, F. Roschangar, D. Vourloumis, Angew. Chem. 1998, 110, 2120-2153; Angew. Chem. Int. Ed. 1998, 37, 2014-2045;
28. e) K. C. Nicolaou, F. Roschangar, D. Vourloumis, Angew. Chem. 1998, 110, 2120-2153; Angew. Chem. Int. Ed. 1998, 37, 2014-2045;
29. f) T. Nishioka, Y. Iwabuchi, H. Irie, S. Hatakeyama, Tetrahedron Lett. 1998, 39, 5597-5600;
30. g) V. P. Kamat, H. Hagiwara, T. Suzuki, M. Ando, J. Chem. Soc. Perkin Trans. 1 1998, 2253-2254;
31. h) K. Arakawa, T. Eguchi, K. Kakinuma, J. Org. Chem. 1998, 63, 4741-4745;
32. i) A. Fürstner, T. Müller, J. Org. Chem. 1998, 63, 424-425;
33. j) S. F. Martin, J. M. Humphrey, A. Ali, M. C. Hillier, J. Am. Chem. Soc. 1999, 121, 866-867;
34. k) see also reference [8b] for a recent review.
35. a) K. C. Nicolaou, N. Winssinger, J. Pastor, S. Ninkovic, F. Sarabia, Y. He, D. Vourloumis, Z. Yang, T. Li, P. Giannakakou, E. Hamel, Nature 1997, 387, 268-272;
36. b) M. Schuster, J. Pernerstorfer, S. Blechert, Angew. Chem. 1996, 108, 2111-2112; Angew. Chem. Int. Ed. Engl. 1996, 35, 1979-1980.
37. b) M. Schuster, J. Pernerstorfer, S. Blechert, Angew. Chem. 1996, 108, 2111-2112; Angew. Chem. Int. Ed. Engl. 1996, 35, 1979-1980.
38. Some representative examples of macrocyclic 1,3-dienes are the macrolactins: A. B. Smith III, G. R. Ott, J. Am. Chem. Soc. 1998, 120, 3935-3948; milbemycins-avermectins: M. T. Crimmins, R. S. Al-Awar, I. M. Vallin, W. G. Hollis, Jr., R. O'Mahony, J. G. Lever, D. M. Bankaitis-Davis, J. Am. Chem. Soc. 1996, 118, 7513-7528; aplyronines: H. Kigoshi, K. Suenaga, T. Mutou, T. Ishigaki, T. Atsumi, H. Ishiwata, A. Sakakura, T. Ogawa, M. Ojika, K. Yamada, J. Org. Chem. 1996, 61, 5326-5351; lasonolide: M. Nowakowski, H. M. R. Hoffmann, Tetrahedron Lett. 1997, 38, 1001-1004.
39. Some representative examples of macrocyclic 1,3-dienes are the macrolactins: A. B. Smith III, G. R. Ott, J. Am. Chem. Soc. 1998, 120, 3935-3948; milbemycins-avermectins: M. T. Crimmins, R. S. Al-Awar, I. M. Vallin, W. G. Hollis, Jr., R. O'Mahony, J. G. Lever, D. M. Bankaitis-Davis, J. Am. Chem. Soc. 1996, 118, 7513-7528; aplyronines: H. Kigoshi, K. Suenaga, T. Mutou, T. Ishigaki, T. Atsumi, H. Ishiwata, A. Sakakura, T. Ogawa, M. Ojika, K. Yamada, J. Org. Chem. 1996, 61, 5326-5351; lasonolide: M. Nowakowski, H. M. R. Hoffmann, Tetrahedron Lett. 1997, 38, 1001-1004.
40. Some representative examples of macrocyclic 1,3-dienes are the macrolactins: A. B. Smith III, G. R. Ott, J. Am. Chem. Soc. 1998, 120, 3935-3948; milbemycins-avermectins: M. T. Crimmins, R. S. Al-Awar, I. M. Vallin, W. G. Hollis, Jr., R. O'Mahony, J. G. Lever, D. M. Bankaitis-Davis, J. Am. Chem. Soc. 1996, 118, 7513-7528; aplyronines: H. Kigoshi, K. Suenaga, T. Mutou, T. Ishigaki, T. Atsumi, H. Ishiwata, A. Sakakura, T. Ogawa, M. Ojika, K. Yamada, J. Org. Chem. 1996, 61, 5326-5351; lasonolide: M. Nowakowski, H. M. R. Hoffmann, Tetrahedron Lett. 1997, 38, 1001-1004.
41. Some representative examples of macrocyclic 1,3-dienes are the macrolactins: A. B. Smith III, G. R. Ott, J. Am. Chem. Soc. 1998, 120, 3935-3948; milbemycins-avermectins: M. T. Crimmins, R. S. Al-Awar, I. M. Vallin, W. G. Hollis, Jr., R. O'Mahony, J. G. Lever, D. M. Bankaitis-Davis, J. Am. Chem. Soc. 1996, 118, 7513-7528; aplyronines: H. Kigoshi, K. Suenaga, T. Mutou, T. Ishigaki, T. Atsumi, H. Ishiwata, A. Sakakura, T. Ogawa, M. Ojika, K. Yamada, J. Org. Chem. 1996, 61, 5326-5351; lasonolide: M. Nowakowski, H. M. R. Hoffmann, Tetrahedron Lett. 1997, 38, 1001-1004.
42. K. C. Nicolaou, T. Ohshima, F. Murphy, S. Barluenga, J. Xu, N. Winssinger, Chem. Commun. 1999, 809-810.